Your browser doesn't support javascript.
loading
Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection.
Perruzza, Lisa; Jaconi, Stefano; Lombardo, Gloria; Pinna, Debora; Strati, Francesco; Morone, Diego; Seehusen, Frauke; Hu, Yue; Bajoria, Sakshi; Xiong, Jian; Kumru, Ozan Selahattin; Joshi, Sangeeta Bagai; Volkin, David Bernard; Piantanida, Renato; Benigni, Fabio; Grassi, Fabio; Corti, Davide; Pizzuto, Matteo Samuele.
Afiliação
  • Perruzza L; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
  • Jaconi S; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
  • Lombardo G; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
  • Pinna D; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
  • Strati F; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
  • Morone D; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
  • Seehusen F; Laboratory for Animal Model Pathology (LAMP), Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • Hu Y; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Xiong J; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, United States.
  • Piantanida R; Department of Otolaryngology-Head and Neck Surgery, Ospedale Regionale di Lugano, Lugano, Switzerland.
  • Benigni F; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
  • Grassi F; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
  • Corti D; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
  • Pizzuto MS; Humabs BioMed SA a Subsidiary of Vir Biotechnology Inc., Bellinzona, Switzerland.
Front Immunol ; 11: 1011, 2020.
Article em En | MEDLINE | ID: mdl-32582158
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Campylobacter / Infecções por Campylobacter / Vacinas Bacterianas / Gastroenterite / Imunoterapia / Mucosa Intestinal / Neutrófilos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Campylobacter / Infecções por Campylobacter / Vacinas Bacterianas / Gastroenterite / Imunoterapia / Mucosa Intestinal / Neutrófilos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article